These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25736816)

  • 1. Potentiation of ciprofloxacin action against Gram-negative bacterial biofilms by a nitroxide.
    Reffuveille F; Fuente-Núñez Cde L; Fairfull-Smith KE; Hancock RE
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25736816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin-nitroxide hybrids with potential for biofilm control.
    Verderosa AD; de la Fuente-Núñez C; Mansour SC; Cao J; Lu TK; Hancock REW; Fairfull-Smith KE
    Eur J Med Chem; 2017 Sep; 138():590-601. PubMed ID: 28709125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Evaluation of Ciprofloxacin-Nitroxide Conjugates as Anti-Biofilm Agents.
    Verderosa AD; Mansour SC; de la Fuente-Núñez C; Hancock RE; Fairfull-Smith KE
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27355936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of lipo-cyclic γ-AApeptides against biofilms of Staphylococcus epidermidis and Pseudomonas aeruginosa.
    Padhee S; Li Y; Cai J
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2565-9. PubMed ID: 25977094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W; Noreddin A
    Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroxide Functionalized Antibiotics Are Promising Eradication Agents against Staphylococcus aureus Biofilms.
    Verderosa AD; Dhouib R; Fairfull-Smith KE; Totsika M
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol oligomers inhibit biofilm formation of Escherichia coli O157:H7 and Pseudomonas aeruginosa.
    Lee JH; Kim YG; Ryu SY; Cho MH; Lee J
    J Nat Prod; 2014 Jan; 77(1):168-72. PubMed ID: 24456071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Pseudomonas aeruginosa and Escherichia coli O157:H7 biofilm formation by plant metabolite ε-viniferin.
    Cho HS; Lee JH; Ryu SY; Joo SW; Cho MH; Lee J
    J Agric Food Chem; 2013 Jul; 61(29):7120-6. PubMed ID: 23819562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
    Gupta S; Agarwal S; Sahoo DR; Muralidharan S
    Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
    Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
    Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction between biofilm formed by Pseudomonas aeruginosa and antibacterial agents].
    Feng X; Zhao G; Cui L; Guan X; Wang H
    Wei Sheng Wu Xue Bao; 2000 Apr; 40(2):210-3. PubMed ID: 12548947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa.
    Barraud N; Hassett DJ; Hwang SH; Rice SA; Kjelleberg S; Webb JS
    J Bacteriol; 2006 Nov; 188(21):7344-53. PubMed ID: 17050922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms.
    Rodríguez-Martínez JM; Ballesta S; Pascual A
    Int J Antimicrob Agents; 2007 Oct; 30(4):366-8. PubMed ID: 17616359
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of Pseudomonas aeruginosa PAO1 Biofilm Protein Profile After Exposure to n-Butanolic Cyclamen coum Extract Alone and in Combination with Ciprofloxacin.
    Shafiei M; Abdi-Ali A; Shahcheraghi F; Vali H; Shahbani Zahiri H; Akbari Noghabi K
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1444-1457. PubMed ID: 28138928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of aptamer-targeted antibiofilm agents for treatment of Pseudomonas aeruginosa biofilms.
    Wang S; Mao B; Wu M; Liang J; Deng L
    Antonie Van Leeuwenhoek; 2018 Feb; 111(2):199-208. PubMed ID: 29098517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambroxol inhibits mucoid conversion of Pseudomonas aeruginosa and contributes to the bactericidal activity of ciprofloxacin against mucoid P. aeruginosa biofilms.
    Wang W; Yu J; He Y; Wang Z; Li F
    APMIS; 2016 Jul; 124(7):611-8. PubMed ID: 27102839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms.
    Gade PAV; Olsen TB; Jensen PØ; Kolpen M; Høiby N; Henneberg KÅ; Sams T
    PLoS One; 2018; 13(6):e0198909. PubMed ID: 29902223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nitroxides on swarming motility and biofilm formation, multicellular behaviors in Pseudomonas aeruginosa.
    de la Fuente-Núñez C; Reffuveille F; Fairfull-Smith KE; Hancock RE
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4877-81. PubMed ID: 23877682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.